1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. AARDVARK THERAPEUTICS INC.
Aardvark Therapeutics Inc. XNAS: AARD
14.98 -0.41 (-2.66%)
234.5K
XNAS Volume

XNAS 14 Jan, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert



Insider Trading disclosures for Aardvark Therapeutics Inc

The latest disclosure was made by Nelson Sun in Aardvark Therapeutics Inc where a trade of 3,000 Common Stock done at an average price of $14.4 was reported to US exchanges on Dec. 11, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Nelson Sun Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 14.40 per share. 11 Dec 2025 3,000 108,484 - 14.4 43,200 Common Stock
Tien-Li Lee Director, Chief Executive Officer, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 14.48 per share. 11 Dec 2025 7,000 1,551,613 - 14.5 101,395 Common Stock
Bryan Jones Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2025 1,250 40,052 - - Stock option (right to buy)
Bryan Jones Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.24 per share. 15 Oct 2025 1,250 1,250 - 4.2 5,300 Common Stock
Tien-Li Lee Director, Chief Executive Officer, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.24 per share. 15 Oct 2025 1,229 1,544,613 - 4.2 5,211 Common Stock
Tien-Li Lee Director, Chief Executive Officer, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2025 1,229 40,566 - - Stock option (right to buy)
Tien-Li Lee Director, Chief Executive Officer, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 9.51 per share. 15 Sep 2025 6,500 1,539,884 - 9.5 61,819 Common Stock
Tien-Li Lee Director, Chief Executive Officer, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 9.94 per share. 15 Sep 2025 3,500 1,543,384 - 9.9 34,805 Common Stock
Tien-Li Lee Director, Chief Executive Officer, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 7.91 per share. 10 Sep 2025 9,000 1,522,384 - 7.9 71,213 Common Stock
Tien-Li Lee Director, Chief Executive Officer, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 7.82 per share. 10 Sep 2025 6,000 1,528,384 - 7.8 46,926 Common Stock
Tien-Li Lee Director, Chief Executive Officer, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 8.50 per share. 10 Sep 2025 5,000 1,533,384 - 8.5 42,516 Common Stock
Nelson Sun Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 8.07 per share. 09 Sep 2025 6,000 105,484 - 8.1 48,440 Common Stock
Tien-Li Lee Director, Chief Executive Officer, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.24 per share. 28 Aug 2025 17,209 1,513,384 - 4.2 72,966 Common Stock
Tien-Li Lee Director, Chief Executive Officer, Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Aug 2025 17,209 41,795 - - Stock option (right to buy)
Nelson Sun Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2025 209,826 209,826 - - Stock Option (right to buy)
Bryan Jones Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2025 122,033 122,033 - - Stock Option (right to buy)
Manasi Jaiman Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2025 126,999 126,999 - - Stock Option (right to buy)
Victor Tong Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2025 61,017 61,017 - - Stock Option (right to buy)
Jeffrey Chi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2025 61,017 61,017 - - Stock Option (right to buy)
Roy D. Baynes Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2025 30,508 30,508 - - Stock Option (right to buy)
Tien-Li Lee Director, Chief Executive Officer, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2025 549,534 549,534 - - Stock option (right to buy)
Susan E. Graf Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2025 30,508 30,508 - - Stock Option (right to buy)
Tien-Li Lee Director, Chief Executive Officer, Ten Percent Owner 14 Feb 2025 350,002 0 - - Series A Convertible Preferred Stock
Nelson Sun Chief Financial Officer 14 Feb 2025 7,001 89,484 - - Common Stock
Nelson Sun Chief Financial Officer 14 Feb 2025 59,332 0 - - Series C Convertible Preferred Stock
Nelson Sun Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 16.00 per share. 14 Feb 2025 10,000 99,484 - 16 160,000 Common Stock
Jeffrey Chi Director 14 Feb 2025 1,130,135 0 - - Series C Convertible Preferred Stock
Jeffrey Chi Director 14 Feb 2025 133,364 133,364 - - Common Stock
Tien-Li Lee Director, Chief Executive Officer, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 16.00 per share. 14 Feb 2025 16,542 1,496,175 - 16 264,672 Common Stock
Tien-Li Lee Director, Chief Executive Officer, Ten Percent Owner 14 Feb 2025 41,303 1,479,633 - - Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures